BlackRock’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $265M | Sell |
9,336,834
-580,637
| -6% | -$16.5M | 0.01% | 1433 |
|
|
2025
Q1 | $293M | Sell |
9,917,471
-14,895
| -0.1% | -$440K | 0.01% | 1356 |
|
|
2024
Q4 | $289M | Buy |
9,932,366
+205,447
| +2% | +$5.97M | 0.01% | 1430 |
|
|
2024
Q3 | $447M | Buy |
9,726,919
+1,104,406
| +13% | +$50.7M | 0.01% | 1153 |
|
|
2024
Q2 | $352M | Buy |
8,622,513
+2,456,522
| +40% | +$100M | 0.01% | 1232 |
|
|
2024
Q1 | $157M | Sell |
6,165,991
-330,602
| -5% | -$8.44M | ﹤0.01% | 1781 |
|
|
2023
Q4 | $58.8M | Buy |
6,496,593
+710,018
| +12% | +$6.43M | ﹤0.01% | 2336 |
|
|
2023
Q3 | $36.9M | Buy |
5,786,575
+27,829
| +0.5% | +$178K | ﹤0.01% | 2541 |
|
|
2023
Q2 | $63.9M | Buy |
5,758,746
+125,321
| +2% | +$1.39M | ﹤0.01% | 2297 |
|
|
2023
Q1 | $86.5M | Buy |
5,633,425
+347,251
| +7% | +$5.33M | ﹤0.01% | 2076 |
|
|
2022
Q4 | $117M | Buy |
5,286,174
+1,164,537
| +28% | +$25.8M | ﹤0.01% | 1884 |
|
|
2022
Q3 | $67.3M | Buy |
4,121,637
+189,975
| +5% | +$3.1M | ﹤0.01% | 2210 |
|
|
2022
Q2 | $57.1M | Buy |
3,931,662
+665,653
| +20% | +$9.67M | ﹤0.01% | 2365 |
|
|
2022
Q1 | $60.3M | Sell |
3,266,009
-31,471
| -1% | -$581K | ﹤0.01% | 2436 |
|
|
2021
Q4 | $78.4M | Buy |
3,297,480
+84,704
| +3% | +$2.01M | ﹤0.01% | 2346 |
|
|
2021
Q3 | $79.1M | Buy |
3,212,776
+512,411
| +19% | +$12.6M | ﹤0.01% | 2334 |
|
|
2021
Q2 | $66.7M | Buy |
2,700,365
+10,638
| +0.4% | +$263K | ﹤0.01% | 2474 |
|
|
2021
Q1 | $58.7M | Buy |
2,689,727
+660,470
| +33% | +$14.4M | ﹤0.01% | 2485 |
|
|
2020
Q4 | $51.8M | Buy |
2,029,257
+734,652
| +57% | +$18.7M | ﹤0.01% | 2404 |
|
|
2020
Q3 | $36.4M | Buy |
1,294,605
+694,605
| +116% | +$19.6M | ﹤0.01% | 2426 |
|
|
2020
Q2 | $17M | Buy |
+600,000
| New | +$17M | ﹤0.01% | 2834 |
|